Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PKC stimulants(Protein kinase C stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H33NO5 |
InChIKeyCOPQMLDDHGHTAG-CNHKJKLMSA-N |
CAS Registry2556373-54-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | AR | 19 Jul 2021 |